Procter & Gamble Health L

NSE: PGHL · Pharmaceuticals · sector

₹5,056.00NSE close 2026-10-26

Key numbers

Market cap₹8,393 cr

Price₹5,056.00

52w high / low₹6,975 / ₹4,707

P/E23.5xSector median 27.9x

P/B16.0xSector median 2.9x

Book value₹316.0

Dividend yield4.06%Sector median 0.48%

ROE67.2%Sector median 11.7%

ROCE93.5%Sector median 12.3%

OPM34.7%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA16.5xSector median 18.6x

Interest cover861.0x

Current ratio2.18x

Sales growth 3y+14.9%Sector median +9.6%

Profit growth 3y+17.9%Sector median +13.3%

PEG1.32x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹185 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 861.0x in the last 12 months.
No promoter shares are pledged.
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 5% of net profit in the last 12 months.
Dividend paid in 5 of the last 5 financial years.
Price ₹5,056.00 on 2026-10-26: -27.5% from the 52-week high, +7.4% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹6,867.00 · low ₹4,802.10

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	313	310	311	339	325	374	370	364
EBITDA	114	123	81	90	120	110	136	131
OPM %	36.4%	39.8%	26.0%	26.7%	37.0%	29.5%	36.6%	36.1%
Other income	3	4	3	4	5	4	4	4
Net profit	82	91	61	66	89	78	95	96
EPS (₹)	49.60	54.76	36.86	39.87	53.34	46.74	56.99	57.92
Revenue YoY					+3.7%	+20.7%	+19.1%	+7.4%
Profit YoY					+7.5%	-14.6%	+54.6%	+45.3%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	819	928	867	934	1,408	1,433
EBITDA	209	279	258	318	457	498
Net profit	151	200	184	234	327	357
EPS (₹)	91.20	120.30	111.00	141.22	196.94	214.99
Revenue growth		+13.4%	-6.6%	+7.7%	+50.7%	+12.6%
Profit growth		+31.9%	-7.7%	+27.3%	+39.5%	+18.7%
Dividend / share (₹)	40.00	97.50	100.00	140.00	155.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+14.9%	+14.2%	+12.6%
Net profit	+17.9%	+18.0%	+18.7%
EPS	+17.9%	+18.0%	–
Share price	–	-1.1% (2y)	-18.2%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	537	525
Borrowings	0	0
Cash & equivalents	189	185
Total assets	794	841
Fixed assets	105	99
Capital work in progress	11	14
Investments	0	0
Receivables	145	164
Inventory	109	137
Payables	172	192

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	169	338
Cash from investing	10	1
Cash from financing	-235	-344
Capex	0	16
Free cash flow	169	322

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	43.7%	62.3%
ROCE %	58.1%	85.9%
Debtor days	57	43
Inventory days	152	137
Payable days	239	192
Cash conversion cycle (days)	-30	-12
Working capital days	122	78

Shareholding

Holder	% (2026-09-30)
Promoters	51.82%
FIIs	6.42%
DIIs	12.63%
of which Mutual funds	8.89%
of which Insurance	3.63%
Public (non-institutions)	29.13%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%

Promoter group	%
Procter and Gamble Overseas India B.V.	51.82%
Gillette India Limited	0.00%
Gillette Diversified Operations Pvt. Ltd.	0.00%
Procter & Gamble Home Products Private Limited	0.00%
Procter & Gamble Hygiene & Health Care Limited	0.00%
Temple Trees Impex And Investment Private Limited	0.00%
1837 LLC	0.00%
Agile Pursuits Franchising, Inc.	0.00%
Agile Pursuits, Inc.	0.00%
Arbora & Ausonia, S.L.U.	0.00%
Braun (Shanghai) Co., Ltd.	0.00%
Braun GmbH	0.00%
Celtic Insurance Company, Inc.	0.00%
Detergent Products Sarl	0.00%
Detergenti S.A.	0.00%

Public holders above 1%	%
Nippon Life India Trustee Ltd-a/c Nippon India SMA	4.18%
Life Insurance Corporation of India	1.87%
Uti-mnc Fund	1.45%
Aditya Birla SUN Life Mutual Fund - Aditya Birla S	1.22%

50,426 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
PGHL	₹8,393 cr	23.5x	16.0x	67.2%	93.5%	34.7%	+14.9%	4.06%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2026-08-27	Dividend	Dividend - Rs 45 Per Share
2026-02-12	Dividend	Interim Dividend - Rs 110 Per Share & Special Dividend Rs 50 Per Share
2025-08-22	Dividend	Dividend - Rs 45 Per Share
2025-02-21	Dividend	Interim Dividend - Rs 80 Per Share
2024-11-28	Dividend	Annual General Meeting/Dividend - Rs 60 Per Share
2024-02-14	Dividend	Interim Dividend - Rs 50 Per Share & Special Dividend Rs 150 Per Share
2023-11-23	Dividend	Annual General Meeting/Dividend - Rs 50 Per Share
2023-02-13	Dividend	Interim Dividend - Rs 45 Per Share
2022-11-15	Dividend	Annual General Meeting/Dividend - Rs 11.50 Per Share
2022-05-12	Dividend	Interim Dividend - Rs 41 Per Share
2021-11-02	Dividend	Annual General Meeting/Dividend - Rs 40 Per Share/Special Dividend - Rs 90 Per Share
2020-11-18	Dividend	Annual General Meeting/Dividend - Rs 42 Per Share Special Dividend - Rs 188 Per Share
2019-05-23	Dividend	Annual General Meeting / Special Dividend - Rs 416 Per Share/ Final Dividend - Rs 24 Per Share
2018-05-21	Dividend	Annual General Meeting/ Dividend - Rs 15 Per Share
2017-05-25	Dividend	Annual General Meeting/Dividend-Rs 11/- Per Share (Revised)
2016-04-22	Dividend	Annual General Meeting/Dividend - Rs 7.50/- Per Share (Book Closure Dates Revised)
2015-03-30	Dividend	Annual General Meeting / Dividend - Rs 6/- Per Share
2014-03-10	Dividend	Annual General Meeting/Dividend - Rs 8.50/- Per Share
2013-03-07	Dividend	Annual General Meeting/Dividend Rs 2.50 Per Share
2012-03-27	Other	Annual General Meeting

Documents

Links go to the original files on the exchange website.

About the company

Manufacture and sale of health care products: Manufacture and sale of healthcare products, viz., vitamins, minerals and supplements


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	PGHL
BSE code	500126
ISIN	INE199A01012
Face value	₹10.0
Incorporated	1967-04-26
Website	www.pghealthindia.com
Plants (India / abroad)	1 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.